Pay in 4 interest-free payments of $7.12 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Image Credit: Meteoritka / Shutterstock In a recent study published in the Journal of Pediatric Endocrinology and Metabolism , researchers compared the efficacy of metformin and GLP-1based therapies, including GLP-1 receptor agonists and the dual GIP/GLP-1 agonist tirzepatide, in youth newly diagnosed with type 2 diabetes (T2D)
Regional Insights North America continues to be the largest market for GLP-1 receptor agonists, owing to the region's high incidence of diabetes and obesity, which are key risk factors for the diseases these drugs target
Ellaway CM, Williams K, Leonard H, et al
Set aside
The key difference lies in the dosage and intended use
US$ 25.69
US$ 20.07
US$ 29.48
US$ 28.20
US$ 19.98
US$ 23.82
US$ 24.95
US$ 29.45
US$ 20.51
US$ 26.85
US$ 23.55
00002-5/asset/c86f6f00-7fc9-46f8-8db8-efb843af04ef/main.assets/fx1.jpg)
